---
title: Concerns about vaccine side effects and public misconceptions
videoId: HR_irr2zyaQ
---

From: [[foundmyfitness]] <br/> 

This article addresses common concerns and misconceptions surrounding [[COVID19 vaccines  Efficacy and safety | COVID-19 vaccines]], including perceived side effects, safety, and efficacy, drawing on scientific data and expert insights.

## Myocarditis and Pericarditis

A concern has been raised regarding the potential for [[COVID19 vaccines  Efficacy and safety | COVID-19 vaccines]] to cause myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the sac surrounding the heart) <a class="yt-timestamp" data-t="00:06:53">[00:06:53]</a>. Data from Israel, published in the *New England Journal of Medicine*, observed almost a million subjects in each arm of a study <a class="yt-timestamp" data-t="00:07:00">[00:07:00]</a>.

This study found that while there is a small signal for myocarditis and pericarditis post-vaccination, the risk of developing these conditions is *more likely* after SARS-CoV-2 infection itself <a class="yt-timestamp" data-t="00:08:04">[00:08:04]</a>. Specifically, young males infected with the virus were found to be up to six times more likely to develop myocarditis compared to those who received the vaccine <a class="yt-timestamp" data-t="00:08:51">[00:08:51]</a>.

Some pre-print articles have been circulated, sometimes making headlines, suggesting a higher incidence of post-vaccine myocarditis than hospitalization from [[Impact of COVID19 on younger populations and long COVID | COVID-19]] in pediatric patients <a class="yt-timestamp" data-t="00:09:11">[00:09:11]</a>. However, these articles often glean data from the Vaccine Adverse Event Reporting System (VAERS), which, while useful for generating hypotheses, is raw, unverified data and not suitable for drawing direct conclusions without further investigation and comparison to background levels of medical problems <a class="yt-timestamp" data-t="00:09:22">[00:09:22]</a>.

## Spike Protein Concerns

A common misconception is that the spike protein generated by [[COVID19 vaccines and Efficacy | COVID-19 vaccines]] is as dangerous as the spike protein from the SARS-CoV-2 virus itself <a class="yt-timestamp" data-t="00:20:02">[00:20:02]</a>.

Key distinctions between the viral spike protein and the vaccine-induced spike protein:
*   **Structure**: The spike protein in vaccines (including Moderna, Pfizer-BioNTech mRNA, Johnson & Johnson adenoviral, and Novavax) has an insertion of two proline amino acids that locks it into a "pre-fusion conformation" <a class="yt-timestamp" data-t="00:22:42">[00:22:42]</a>. This means it cannot undergo the structural change (elongation and twisting) that allows the actual SARS-CoV-2 virus to fuse with and enter human cells <a class="yt-timestamp" data-t="00:23:50">[00:23:50]</a>. This critical modification was developed by Dr. Jason McLellan <a class="yt-timestamp" data-t="00:22:55">[00:22:55]</a>.
*   **Quantity**: A single SARS-CoV-2 viral particle has about 26 spike proteins on its surface <a class="yt-timestamp" data-t="00:20:50">[00:20:50]</a>, and thousands of viral particles can replicate within cells during an infection <a class="yt-timestamp" data-t="00:27:06">[00:27:06]</a>. The vaccine only instructs a limited number of cells to produce the modified spike protein <a class="yt-timestamp" data-t="01:18:36">[01:18:36]</a>.
*   **Location**: The spike protein produced by the vaccine is expressed on the cell surface (plasma membrane) and contains a transmembrane domain that anchors it there, preventing it from freely floating throughout the circulation <a class="yt-timestamp" data-t="00:30:14">[00:30:14]</a>. In contrast, the actual SARS-CoV-2 virus and its spike protein have been detected in multiple organs in humans, including the heart, brain, cerebrospinal fluid, kidneys, GI tract, testes, and plasma <a class="yt-timestamp" data-t="00:27:14">[00:27:14]</a>.

Concerns about vaccine spike protein traveling to other organs often stem from studies in rodents that used doses 10 times higher than those given to humans <a class="yt-timestamp" data-t="00:30:46">[00:30:46]</a>. When a more equivalent dose was given to mice, the vaccine predominantly stayed in the muscle tissue or cleared from the liver within 48 hours <a class="yt-timestamp" data-t="00:32:13">[00:32:13]</a>. Any minor spillover into the lymphatic system is part of the immune response, where immune cells process and recycle components <a class="yt-timestamp" data-t="00:32:51">[00:32:51]</a>.

A small human study suggesting vaccine spike protein detection in plasma used an assay with a 25% false positivity rate, making its conclusions unreliable given the sample size <a class="yt-timestamp" data-t="00:34:23">[00:34:23]</a>.

## Interpreting VAERS Data: [[Methodological flaws in studies on vitamin supplementation | Methodological Flaws]] and Public Misconceptions

The Vaccine Adverse Event Reporting System (VAERS) in the United States is a publicly accessible database where anyone can submit reports of adverse events following vaccination <a class="yt-timestamp" data-t="00:37:38">[00:37:38]</a>. For [[COVID19 vaccines and Efficacy | COVID-19 vaccines]], healthcare providers are *required by law* to report *all serious adverse health events*, including death, regardless of whether they believe the vaccine caused the event <a class="yt-timestamp" data-t="00:38:51">[00:38:51]</a>.

This broad reporting requirement, combined with high public interest, leads to a significant increase in reported events, not necessarily an increase in actual adverse events caused by the vaccine. An analogy is seen with the 2009 H1N1 influenza vaccine; increased vaccination rates and public awareness led to more reports, but studies found no new or unexpected patterns in adverse outcomes <a class="yt-timestamp" data-t="00:41:16">[00:41:16]</a>.

### Misinterpretations of VAERS Data

*   **Raw Numbers vs. Causation**: Simply observing a "spike" in reported deaths post-vaccine in VAERS does not equate to the vaccine causing those deaths <a class="yt-timestamp" data-t="00:38:02">[00:38:02]</a>. Epidemiologists and scientists analyze this data by stratifying it by age, gender, ethnicity, and comparing it to normal background rates of medical problems and deaths <a class="yt-timestamp" data-t="00:48:35">[00:48:35]</a>.
*   **Background Death Rates**: The U.S. death rate is approximately 870 deaths per 100,000 people per year <a class="yt-timestamp" data-t="00:43:26">[00:43:26]</a>. Given over 166 million people vaccinated over several months, statistically, approximately 421,000 deaths would be expected to occur by chance within the vaccinated population during that period, completely independent of the vaccine <a class="yt-timestamp" data-t="00:44:55">[00:44:55]</a>. The actual reported VAERS deaths (around 10,000-15,000) are significantly *lower* than this background expectation, suggesting significant underreporting of non-causal events <a class="yt-timestamp" data-t="00:45:09">[00:45:09]</a>. This indicates that it is highly unlikely a significant number of deaths are happening *from* the [[COVID19 vaccines and Efficacy | COVID-19 vaccines]] <a class="yt-timestamp" data-t="00:54:10">[00:54:10]</a>.
*   **Timing of Reports**: The observation that most deaths are reported within one or two days of vaccination, then precipitously decline, is consistent with human psychology and reporting bias rather than actual causation <a class="yt-timestamp" data-t="00:46:59">[00:46:59]</a>. People are more likely to report an event if it occurs soon after vaccination <a class="yt-timestamp" data-t="00:46:43">[00:46:43]</a>.
*   **Identifying True Signals**: Agencies like the CDC and FDA *do* analyze VAERS data to identify genuine safety signals. For example, the link between myocarditis and mRNA vaccines, and rare blood clots with the Johnson & Johnson vaccine, were identified through this rigorous analysis, demonstrating transparency <a class="yt-timestamp" data-t="00:54:21">[00:54:21]</a>.
*   **Risk Comparison**: When comparing the likelihood of death, individuals are consistently much more likely to die from [[Impact of COVID19 on younger populations and long COVID | COVID-19]] infection than from a vaccine across all age groups <a class="yt-timestamp" data-t="00:51:07">[00:51:07]</a>. For instance, those aged 18-39 are about 17 times more likely to die from COVID-19 than from a vaccine <a class="yt-timestamp" data-t="00:52:11">[00:52:11]</a>.

## Impact on Human Fertility

Concerns about [[COVID19 vaccines and Efficacy | COVID-19 vaccines]] impacting human fertility have circulated <a class="yt-timestamp" data-t="01:09:22">[01:09:22]</a>. One theory suggested antibodies made against the vaccine might cross-react with proteins in the placenta <a class="yt-timestamp" data-t="01:09:37">[01:09:37]</a>.

However, data from phase three clinical trials for major vaccines (Pfizer, Moderna, AstraZeneca, Johnson & Johnson) showed no statistical significant difference in the number of pregnancies or miscarriages between vaccinated and control groups <a class="yt-timestamp" data-t="01:10:17">[01:10:17]</a>.

Post-marketing surveillance, including a study published in the *New England Journal of Medicine*, also found no statistically significant difference in rates of pregnancy loss, spontaneous abortions, stillbirth, preterm births, congenital abnormalities, or neonatal death in vaccinated pregnant individuals compared to the general population <a class="yt-timestamp" data-t="01:11:07">[01:11:07]</a>. A follow-up pre-print study found the miscarriage rate in vaccinated women (12.8%) to be on the low end of the normal range (12.5% to 18.7%) <a class="yt-timestamp" data-t="01:12:59">[01:12:59]</a>.

Furthermore, studies have shown that neither previous SARS-CoV-2 infection nor [[COVID19 vaccines and Efficacy | COVID-19 vaccines]] affected embryo implantation <a class="yt-timestamp" data-t="01:13:20">[01:13:20]</a>. A small study on male fertility also found no effect of [[COVID19 vaccines and Efficacy | COVID-19 vaccines]] on normal sperm parameters <a class="yt-timestamp" data-t="01:13:46">[01:13:46]</a>.

## mRNA Vaccines as "Gene Therapy"

The concept of mRNA vaccine technology being "gene therapy" that alters human DNA is a significant misconception <a class="yt-timestamp" data-t="01:15:31">[01:15:31]</a>.

*   **Cellular Location**: Human DNA resides within the nucleus of the cell <a class="yt-timestamp" data-t="01:15:54">[01:15:54]</a>. The mRNA in vaccines does not contain a "nuclear localization sequence," which is required for anything to enter the nucleus <a class="yt-timestamp" data-t="01:16:14">[01:16:14]</a>.
*   **Central Dogma**: The fundamental principle of molecular biology states that DNA goes to RNA, and RNA goes to protein <a class="yt-timestamp" data-t="01:18:02">[01:18:02]</a>. mRNA vaccines simply instruct ribosomes (which are located in the outer part of the cell, outside the nucleus) to make the spike protein <a class="yt-timestamp" data-t="01:18:16">[01:18:16]</a>. This process is similar to how a virus itself uses cell machinery, but the vaccine does not involve the nucleus or DNA <a class="yt-timestamp" data-t="01:18:55">[01:18:55]</a>.
*   **Enzymes for DNA Alteration**: For mRNA to alter DNA, it would first need to become DNA, requiring an enzyme called reverse transcriptase, which is not present in the nucleus or the vaccine <a class="yt-timestamp" data-t="01:16:56">[01:16:56]</a>. Even if that happened, an integrase enzyme would be needed to integrate the new DNA into our existing DNA, which is also not present <a class="yt-timestamp" data-t="01:17:24">[01:17:24]</a>.
*   **History of mRNA Technology**: This technology is not new; it has been researched for over 30 years <a class="yt-timestamp" data-t="02:14:21">[02:14:21]</a>. The first injection of mRNA into mouse muscle cells occurred in the 1990s <a class="yt-timestamp" data-t="02:13:28">[02:13:28]</a>. Modifications to mRNA nucleotides to prolong their stability were made by 2005 <a class="yt-timestamp" data-t="02:13:42">[02:13:42]</a>. Clinical trials using mRNA technology in humans for various purposes, including cancer immunotherapy and treatment for heart failure, date back to 2001 <a class="yt-timestamp" data-t="02:15:31">[02:15:31]</a>. The rapid development of [[COVID19 vaccines and Efficacy | COVID-19 vaccines]] was due to accelerated funding and manufacturing processes, not skipped safety steps <a class="yt-timestamp" data-t="02:09:20">[02:09:20]</a>.

## Vaccine Impact on Viral Virulence

The idea that vaccines can make the SARS-CoV-2 virus more deadly or virulent by applying selective pressure is a concern <a class="yt-timestamp" data-t="01:56:16">[01:56:16]</a>.

*   **Viral Evolution**: Viruses are primarily under selective pressure to become *more transmissible*, not necessarily more virulent <a class="yt-timestamp" data-t="01:58:04">[01:58:04]</a>. It is not in the virus's best interest to kill its host quickly, as this limits its ability to reproduce and infect more individuals <a class="yt-timestamp" data-t="01:58:10">[01:58:10]</a>. Virulence can sometimes "hitchhike" alongside increased transmissibility, but it's not directly selected for <a class="yt-timestamp" data-t="01:58:39">[01:58:39]</a>.
*   **Vaccination and Mutation**: Viral replication is necessary for variants to emerge (due to errors in replication) <a class="yt-timestamp" data-t="02:04:16">[02:04:16]</a>. Most variants (Alpha, Beta, Gamma, Delta) originated in unvaccinated populations with high levels of viral replication <a class="yt-timestamp" data-t="02:04:33">[02:04:33]</a>. Vaccinated individuals, by reducing overall and onward transmission (clearing the virus faster and having lower viral loads), *reduce* the chances for the virus to replicate and mutate <a class="yt-timestamp" data-t="02:01:51">[02:01:51]</a>.
*   **Vaccine Evasion vs. Virulence**: "Vaccine escape" (variants that evade vaccine-induced antibodies) is a different phenomenon from a vaccine causing a more virulent strain <a class="yt-timestamp" data-t="02:03:01">[02:03:01]</a>. There is no evidence of human vaccines causing more virulent strains of a virus <a class="yt-timestamp" data-t="02:02:50">[02:02:50]</a>.
*   **T-Cell Response**: While antibody responses may wane, the T-cell response, another crucial aspect of the immune system, continues to offer significant protection against severe disease and hospitalization <a class="yt-timestamp" data-t="02:06:27">[02:06:27]</a>. T-cells recognize infected cells and can even mutate alongside the virus to maintain effectiveness <a class="yt-timestamp" data-t="02:05:33">[02:05:33]</a>.

## Conclusion

The [[COVID19 vaccines  Efficacy and safety | COVID-19 vaccines]] have demonstrated substantial effectiveness in preventing severe illness, hospitalization, and death, even against variants like Delta <a class="yt-timestamp" data-t="02:21:04">[02:21:04]</a>. While the process of vaccine development was accelerated, no critical safety steps were skipped <a class="yt-timestamp" data-t="02:10:24">[02:10:24]</a>. The accelerated timeline was largely due to unprecedented financial investment and simultaneous rather than sequential research and manufacturing phases <a class="yt-timestamp" data-t="02:10:36">[02:10:36]</a>. This has led to an explosion of promising research in mRNA technology for various diseases, including cancer and genetic disorders <a class="yt-timestamp" data-t="02:16:51">[02:16:51]</a>.

Understanding the scientific data and proper interpretation of reporting systems is crucial to addressing public [[safety_concerns_and_misconceptions_about_cruciferous_vegetables | misconceptions]] and making informed health decisions.